KREMER LASER SYSTEM

FDA Premarket Approval P970005

Pre-market Approval Supplement Details

Approval for a single laser, kremer excimer laser system serial no. Kea940202. This device, using a 6. 0 mm ablation zone, is indicated for myopic and astigmatic laser in situ keratomileusis (lasik) in patients: 1)with myopia ranging between -1. 0 and -15. 0 diopters (d) with or without astigmatism ranging from 0. 0 d to 5. 00 d; 2) who are 18 years of age or older; and 3) with stable refraction over the 1-year period prior to surgery. Note: patients between 18 and 20 years old should not demonstrate a shift in refraction greater than 0. 5d. Patients 21 years and older should not demonstrate a shift greater than 1. 0 d.

DeviceKREMER LASER SYSTEM
Generic NameExcimer Laser System
ApplicantLASERSIGHT TECHNOLOGIES, INC.
Date Received1997-01-31
Decision Date1998-07-30
PMAP970005
SupplementS
Product CodeLZS 
Docket Number00M-0811
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address LASERSIGHT TECHNOLOGIES, INC. 6848 Stapoint Court winter Park, FL 32792
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

A PHP Error was encountered

Severity: Notice

Message: Undefined offset: 0

Filename: fda.report/pma_item.php

Line Number: 133

Backtrace:

File: /var/www/fda.report/pma_item.php
Line: 133
Function: _error_handler

Supplement NumberDateSupplement Type
P970005Original Filing

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.